Connacht Asset Management’s Bausch Health BHC Stock Holding History

Connacht Asset Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-125,000	Closed	-$1.04M	–	127
2022 Q2	$1.04M	Buy	+125,000	New	+$1.75M	0.44%	62

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Connacht Asset Management's BHC Position: Q2 2022 in Review

Connacht Asset Management sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 59,043 shares — an estimated $825K sold.

Connacht Asset Management first reported a position in BHC in Q4 2020 and held it in 6 quarters. The position peaked at $2.65M in Q1 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

Connacht Asset Management reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
Connacht Asset Management sold 59,043 Bausch Health shares in Q2 2022, an estimated $825K.
Connacht Asset Management first reported a position in Bausch Health in Q4 2020 and held it in 6 quarters.
Connacht Asset Management's Bausch Health position peaked at $2.65M in Q1 2021.
327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Connacht Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.